← Leaderboards
Kavindra Nath
University Of Pennsylvania
$1,790,103
Attributed
$4,100,263
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$4,100,263 · 4
By mechanism
R01$3,682,435 · 3
R21$417,828 · 1
Top collaborators
- Mariusz A Wasik5 shared
- Jerry D Glickson3 shared
- Fernando Arias-Mendoza2 shared
- Ian Alexander Blair2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Jerry D Glickson$20,468,757
- Meenhard Herlyn$50,214,821
- Arjun Raj$12,538,737
- Ronen Marmorstein$40,497,435
- Wei Guo$15,763,941
Others in their field
Other Rising Stars on “Biological Markers”
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Suma Babu · Massachusetts General Hospital$25,163,692
- Sabrina Paganoni · Massachusetts General Hospital$25,163,692
- Christina Millin · Rho Federal Systems Division, Inc.$23,515,000
- Jinsy Andrews · Columbia University Health Sciences$21,294,649
- Supriya Menezes · The Emmes Company, Llc$18,394,958
Research focus
Biological MarkersPathway InteractionsTreatment ResponseTumorMetabolicCellsResponseSignal TransductionMetabolismTumor VolumeResponse BiomarkerMonitorNeoplastic CellCell LineMetabolic PathwayMetabolomicsNon-Invasive ImagingKinase InhibitorInhibitorImaging ModalityDetectionIn VivoInhibitor TherapyMalignant Neoplasms
Grant awards (9)
Metabolic Imaging of Targeted Therapies in Cancer$609,855
R01 · FY2025 · CA · contact PI
Translation of Noninvasive Metabolic Biomarkers to Targeted Therapy for Cancer$227,906
R21 · FY2025 · CA · contact PI
Metabolic Imaging of Targeted Therapies in Cancer$579,363
R01 · FY2024 · CA · contact PI
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition$477,166
R01 · FY2024 · CA · contact PI
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy$455,881
R01 · FY2024 · CA · contact PI
Translation of Noninvasive Metabolic Biomarkers to Targeted Therapy for Cancer$189,922
R21 · FY2024 · CA · contact PI
Metabolic Imaging of Targeted Therapies in Cancer$597,658
R01 · FY2023 · CA · contact PI
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition$492,237
R01 · FY2023 · CA · contact PI
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy$470,275
R01 · FY2023 · CA · contact PI